Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical Trial

11/10/2013

Alabama, California, Colorado, Connecticut, Florida, Indiana, Maryland, Massachusetts, Michigan, Missouri, New York, North Carolina, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Wisconsin, Argentina, Australia, Canada, Denmark, France, Germany, Ireland, Italy, Japan, Mexico, Puerto Rico, Spain, South Korea, Sweden, Taiwan, United Kingdom. clinicaltrials.gov

Published in Brief:

SmartBrief Job Listings for Health Care